Kiniksa Pharmaceuticals International (KNSA) Selling, General & Administrative (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.13 Bn | 5.60 Bn | 220.03 Mn | 63.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.87 Mn |
| Mar 31, 2026 | 61.15 Mn |
| Dec 31, 2025 | 56.78 Mn |
| Sep 30, 2025 | 49.10 Mn |
| Jun 30, 2025 | 46.86 Mn |
| Mar 31, 2025 | 43.53 Mn |
| Dec 31, 2024 | 40.54 Mn |
| Sep 30, 2024 | 46.40 Mn |
| Jun 30, 2024 | 42.40 Mn |
| Mar 31, 2024 | 38.68 Mn |
| Dec 31, 2023 | 36.74 Mn |
| Sep 30, 2023 | 34.47 Mn |
| Jun 30, 2023 | 29.18 Mn |
| Mar 31, 2023 | 29.05 Mn |
| Dec 31, 2022 | 27.22 Mn |
| Sep 30, 2022 | 24.68 Mn |
| Jun 30, 2022 | 23.84 Mn |
| Mar 31, 2022 | 22.22 Mn |
| Dec 31, 2021 | 22.74 Mn |
| Sep 30, 2021 | 20.76 Mn |